Who has been buying Lameditech stock?

0 distinct insiders have filed 0 disclosed insider purchases in Lameditech (462510), most recently on 2025-09-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Lameditech have?

Lameditech has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-06-17 to 2025-09-19.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Lameditech 462510

Company

라메디텍Lameditech

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2025-09-19

Lameditech (462510) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Lameditech is dated 2024-06-17; the most recent is 2025-09-19.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2025-09-19	BUY	주식매수청구권 행사	장창욱 Changwook Jang	CFO/Vice President	32.0K	₩7,020	-27.5%	₩225M ($156K)
2025-06-20	BUY	기타	강민정 Minjeong Kang	moving	2.5K	₩8,230	-38.1%	₩21M ($14K)
2025-03-21	BUY	주식매수청구권 행사	정봉균 Jeong Bong-gyun	Managing Director	55.2K	₩7,730	-34.1%	₩427M ($296K)
2025-03-21	BUY	주식매수청구권 행사	장창욱 Changwook Jang	CFO/Vice President	15.0K	₩7,730	-34.1%	₩116M ($81K)
2025-03-21	BUY	주식매수청구권 행사	임채승 Lim Chae-seung	Other non-executive directors	50.0K	₩7,730	-34.1%	₩387M ($268K)
2024-06-17	BUY	신규보고	박병철 Park Byeong-cheol	Managing Director	176.7K	₩24,550	-79.3%	₩4.3B ($3.0M)
2024-06-17	BUY	신규보고	임채승 Lim Chae-seung	Other non-executive directors	19.3K	₩24,550	-79.3%	₩473M ($328K)
2024-06-17	BUY	신규보고	최종석 Choi Jong-seok	CEO	2.2M	₩24,550	-79.3%	₩53.6B ($37.3M)
2024-06-17	BUY	신규보고	백광열 Baek Gwang-yeol	moving	1.5K	₩24,550	-79.3%	₩37M ($26K)
2024-06-17	BUY	신규보고	장창욱 Changwook Jang	CFO/Executive Director	132.1K	₩24,550	-79.3%	₩3.2B ($2.3M)

Frequently asked questions

Who has been buying Lameditech stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Lameditech (462510), most recently on 2025-09-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Lameditech have?: Lameditech has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-06-17 to 2025-09-19.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.